Application of AGREEⅡ in evaluating quality of esophageal cancer screening practice guidelines
10.3760/cma.j.cn112338-20200828-01105
- VernacularTitle:AGREEⅡ在评价食管癌筛查实践指南质量中的应用
- Author:
Xuan LIU
1
;
Yifang ZHANG
;
Yongle ZHAN
;
Hexin YUE
;
Luting GUI
;
Feng BIAN
;
Yuping WANG
;
Yu JIANG
Author Information
1. 中国医学科学院/北京协和医学院群医学及公共卫生学院,北京 100730
- Keywords:
Appraisal of Guidelines for Research & Evaluation InstrumentⅡ;
Clinical practice guideline;
Quality assessment;
Evidence-based decision-making
- From:
Chinese Journal of Epidemiology
2021;42(7):1312-1317
- CountryChina
- Language:Chinese
-
Abstract:
High-quality clinical practice guidelines are of great significance for standardizing the clinical diagnosis and treatment process and improving the overall quality of health care. The Appraisal of Guidelines for Research & Evaluation InstrumentⅡ (AGREEⅡ) is one of the recognized tools for the evaluation of the quality of clinical practice guidelines. It has been translated into Chinese and is widely used in guideline formulation and quality evaluation. This article intends to take the comparatively high-quality clinical practice guidelines in the field of esophageal cancer screening in China, i.e. "Expert Consensus on Early Esophageal Cancer and Precancerous Lesion Screening in China (2019, Xinxiang)" as an example, to interpret the use of AGREEⅡ item by item, which might provide a reference for medical and health workers to better understand and use the assessment tool.